Abstract
During brain development, one of the most important structures is the subventricular zone (SVZ) from which most neurons are generated. In adulthood, the SVZ maintains a pool of progenitor cells that continuously replace neurons in the olfactory bulb. Neurodegenerative diseases induce a substantial upregulation or downregulation of SVZ progenitor cell proliferation, depending on the type of disorder. Far from being a dormant layer, the SVZ responds to neurodegenerative disease in a way that makes it a potential target for therapeutic intervention.
Patients with Parkinson’s disease experience tremors, slurred speed, and slowness of movement that eventually progresses to total paralysis. In this progressive, debilitating illness, the cells in a small part of the brain called the substantia nigra are destroyed, depriving the striatum (the part of the brain that controls movement) of a critical molecule called dopamine. Despite devastating loss of motor control, mental faculties in Parkinson’s patients remain intact, and while the disease is in itself not fatal, patients often succumb to complications such as injuries from falls or pneumonia. Parkinson’s disease (PD) is also an intractable degenerative neurological disorder that affects nerve cells in the part of the brain controlling muscle movement.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Curtis MA, Faull RLM, Eriksson PS. The effect of neurodegenerative diseases on the subventricular zone. Nat Rev Neurosci. 2007;8:712-723.
Walton-Hadlock JL, Fahn S, Keiburtz K, Tanner CM. Levodopa and the progression of parkinson’s disease. New Engl J Med. 2005;352:1386.
Obeso JA, Guridi J, Rodriguez-Oroz MC, et al. Deep brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. New Engl J Med. 2001;345(13):956-963.
López-Lozano JJ, Bravo G, Abascal J, Brera B, Millan I. Clinical outcome of cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson’s disease. Clínica Puerta de Hierro Neural Transplantation Group. J Neurosurg. 1999 May;90(5):875-882.
Grégoire Courtine, Yury Gerasimenko, Rubia van den Brand, et al. Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. Nat Neurosci. 2009;12:1333-1342.
Bhattacharya N, Mukherjee K, Chhetri MK, Banerjee T, Mani U, Bhattacharya S. A study report of 174 units of placental umbilical whole blood transfusion in 62 patients as a rich source of fetal hemoglobin supply in different indications of blood transfusion. Clin Exp Obst Gynecol. 2001;28(1):47-52.
Bhattacharya N, Mukherjee KL, Chhetri MK, et al. An unique experience with human pre-immune (12 weeks) and hypo-immune (16 weeks) fetal thymus transplant in a vascular subcutaneous axillary fold in patients with advanced cancer – a report of two cases. Eur J Gyn Oncol. 2001;22(4):273-277.
Bhattacharya N. Fetal tissue / organ transplant in HLA randomized adults’ vascular subcutaneous axillary fold – a preliminary report of 14 patients. Clin Exp Obst Gynecol. 2001;28(4):233-239.
Bhattacharya N. Fetal cell/tissue therapy in adult disease – A new horizon in regenerative medicine. Clin Exp Obst Gynecol. 2004;31:167-173.
Thomas M, Yang L, Hornsby PJ. Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase. Nat Biotechnol. 2000;18(1):39-42.
Bhattacharya N, Chaudhuri N, Banerjee S, Mukherjee KL. Intraamniotic tetanus toxoid as a safe abortifacient. Ind J Med Res. 1979;70:435-439.
Bhattacharya N. Letter to the editor. Clin Exp Obst Gynecol. 1996;23:272-275.
Bhattacharya N (1996) Intraamniotic instillation of tetanus toxoid: A safe, cheap, effective abortifaecient in the light of our experiences with different intraamniotic instillation of antigens for alteration of pregnancy immunotolerance – A study from 1978 to 1996. In Tambiraja RL, Ho NK, eds. Relevance and Excellence in Perinatal Care, Proceedings of the 9th Congress of the Federation of the Asia and Oceania Perinatal Societies, Singapore, Nov. 1996, Monduzzi Editore, Bolonga, Italy, pp 193–200.
Bhattacharya N (1996) Dissolution of the fetus: A new experience with intraamniotic BCG instillation. In: Tambiraja RL, Ho NK, eds. Relevance and Excellence in Perinatal Care, Proceedings of the 9th Congress of the Federation of the Asia and Oceania Perinatal Societies, Singapore, Nov. 1996, Monduzzi Editore, Bolonga, Italy, pp 201–206.
Bhattacharya N (1996) Study of the aborted fetus after intraamniotic instillation of tetanus toxoid. In: Tambiraja RL, Ho NK, eds. Relevance and Excellence in Perinatal Care, Proceedings of the 9th Congress of the Federation of the Asia and Oceania Perinatal Societies, Singapore, Nov. 1996, Monduzzi Editore, Bolonga, Italy, pp 187–192.
Bhattacharya N (2001) A study on the intraamniotic instillation of tetanus toxoid on a growing human fetus. D. Sc. dissertation, Faculty of Medicine, Calcutta University Kolkata
Deacon T, Schumacher J, Dinsmore J, Thomas C, et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with parkinson’s disease. Nat Med. 1997;3(3):350-353.
Freed CR, Green PE, Breeze RE, Tsai WY. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. New Engl J Med. 2001;344:710-719.
Wenning GK, Ordin P, Morrish P, Rehncrona S. Short and long term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson’s disease. Ann Neurol. 1997;42(1):95-107.
Hoffer B, van Horne C. Survival of dopaminergic neurons in fetal tissue graft. New Engl J Med. 1995;332(17):1163-1164.
Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatr. 2008;79(4):368-376.
Fahn S, Elton RL. Members of the UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson’s disease, vol. 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163.
Hoehn MM, Yahr MD. Parkinsonism, onset, progression and mortality. Neurology. 1967;17:427-435.
Parashos SA, Johnson ML, Erickson-Davis C, Wielinski CL (2000). Assessing cognition in parkinson disease: use of the cognitive linguistic quick test. J Geriatr Psychiatr Neurol. 2009;22(4):228-234.
Zigmnond AS, Snaith RP. The hospital anxiety and depression-scale. Acta Psychiatr Scand. l983;67:361-370.
Snaith RP, Taylor CM (1985) Rating scgles for depression and anxiety:a current perspective. Br J Clin Pharmacol. 19:17S-20S.
Channer KS, James MA, Papouchado M, Res JR. Anxiety and depression in patients with chest pain referred for exercise testing. Lancet. 1985;ii:820-822.
Snaith RP, Zigmond AS. The Hospital Anxiety and Depression Scale Manual. Windsor: NFER, Nelson; 1994.
Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev. 2002;16:87-96.
Acasoy MO. Non haematopoietic biological effect of erythropoietin. Br J Haematol. 2008;141(1):14-31.
Juul S. Erythropoietin in the central nervous system and its use to prevent hypoxicischaemic brain injury. Acta Paediatr Suppl. 2002;91:36-42.
Juul S. Nonerythropoietic roles of erythropoietin in the fetus and neonate. Clin Perinatol. 2000;27(3):527-541.
Melzack R. The McGill pain questionnaire: major properties and scoring method. Pain. 1975;1:277-299.
Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30(2):191-197.
Goldstein A, Lowry PJ. Effect of the opiate antagonist naloxone on body temperature in rats. Life Science. 1975;17(6):927-931.
Catherine Saint Louis, “Exercise Test: Truth or Myth”, Published: March 27, 2008, New York Times.
Waste management – cytokines, growth factors and cachexia, 2006;17(6): 475–486. Epub 2006 Nov 22
Miller RK (1991) Fetal drug therapy: Principles and Issues. In: Pitkin MR and Scott JR, eds, Clin. Obst. Gynecol. 34(2), 241–250.
Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Ann Neurol. 2003;54:403-414.
Guyton SE, Hall JE. Text Book of Medical Physiology. 10th ed. Philadelphia, PA: Harcourt Asia Pvt. Ltd, Saunders Company; 1997:709-714.
Stocum DL. Regeneration biology and engineering: Strategies for tissue restoration. Comment Wound Repair Regen. 1998;6(4):273-275.
Bjorklund A, Dunnett SB. Neural transplants in Parkinson’s disease: do they work? Forum, Neural transplantation for the treatment of Parkinson’s disease. Lancet Neurol. 2003;2:437-445.
Acknowledgment
The author acknowledges with gratitude the support of the patients of advanced Parkinsonism and their families for the support and enthusiasm received for this research program. The author also acknowledges the support of the mothers who donated their aborted fetus for the research project. The author gratefully appreciates the financial support from the Department of Science and Technology, Government of West Bengal, Calcutta.
The author acknowledges with gratitude the support and overall guidance of Prof M. K. Chhetri of AMRI. Prof K. L. Mukherjee of Mahatma Gandhi Clinical Research Laboratory helped in dsDNA, ANA, and Ferritin estimation. The author also thanks the research associates of the project, Dr Bimal Samanta, Dr Mohua Bhattacharya, Dr Asit Ghosh, Dr Ronjit Nandi, Dr Bonya Biswas, and Dr S. P. Das for their material support. Mrs Seema Das, Clinical Psychologist, assisted in the HAD and MMSE scoring of the patients. Prof Sanjukta Bhattacharya, Jadavpur University, Calcutta, is duly acknowledged for her editorial assistance.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer London
About this chapter
Cite this chapter
Bhattacharya, N. (2011). A Study and Follow-up (1999–2009) of Human Fetal Neuronal Tissue Transplants at a Heterotopic Site Outside the Brain in Cases of Advanced Idiopathic Parkinsonism. In: Bhattacharya, N., Stubblefield, P. (eds) Regenerative Medicine Using Pregnancy-Specific Biological Substances. Springer, London. https://doi.org/10.1007/978-1-84882-718-9_39
Download citation
DOI: https://doi.org/10.1007/978-1-84882-718-9_39
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-717-2
Online ISBN: 978-1-84882-718-9
eBook Packages: MedicineMedicine (R0)